HDVY (Health Discovery) Research & Development: $0.00 Mil (TTM As of Sep. 2021)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Health Discovery Research & Development?

Health Discovery HDVY Research & Development is $0.00 Mil as of Sep. 2021.

Research & Development is the aggregate amount of research and development expenses during the year. Health Discovery's Research & Development for the three months ended in Sep. 2021 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2021 was $0.00 Mil.

Health Discovery  (OTCPK:HDVY) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Health Discovery Research & Development Related Terms

Health Discovery Research & Development Historical Data

* Premium members only.

The historical data trend for Health Discovery's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Health Discovery Research & Development Chart

Health Discovery Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.00 0.00 0.00 0.00

Health Discovery Quarterly Data
Mar16 Jun16 Sep16 Dec16 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Health Discovery Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
Health Discovery (HDVY) has a Research & Development of $0.00 Mil as of Sep. 2021. Research and development expense is the total cost for research and development activities. View historical data on Health Discovery and its competitors.
Is Health Discovery's Research & Development too high?
Health Discovery's current Research & Development is $0.00 Mil.
How does Health Discovery's Research & Development compare to SSYNF and PAXH?
Health Discovery's Research & Development of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Health Discovery and its competitors. Health Discovery's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health Discovery stock overvalued right now?
Health Discovery (HDVY) has a current Research & Development of $0.00 Mil. The current Research & Development is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Health Discovery (HDVY), the current Research & Development is $0.00 Mil as of Sep. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Health Discovery Business Description

Address 2002 Summit Boulevard, NE Suite 300, Atlanta, GA, USA, 30319
Health Discovery Corp is a machine learning company that uses advanced mathematical techniques to analyze large amounts of data to uncover patterns that might otherwise be undetectable. The company operates in the field of molecular diagnostics where such tools are critical to scientific discovery. It owns a patent portfolio of machine learning technology, including certain pioneer patents on Support Vector Machine. The company recognizes revenue principally from license and royalty fees for intellectual property and from development agreements with research partners.